For research purposes only. Not for human or veterinary use.
Retatrutide is a synthetic peptide triple agonist acting on the GIP, GLP-1, and glucagon receptors. Research has examined its combined incretin and glucagon-pathway activity, studied in metabolic research models for effects on energy expenditure, adipose tissue metabolism, and glycemic regulation.
For research purposes only. Not for human or veterinary use.